News & Insights

News and Industry Insights

The Future of Specialty Contact Lenses

News

Specialty contact lenses are entering a new era in which technology is changing not only how lenses are designed and fitted, but also what contact lenses may ultimately be capable of doing. According to Melissa Barnett, OD, FAAO, FSLS, and Avani Davé, OD, FAAO, advances in imaging, impression-guided design, artificial intelligence (AI), and smart contact-lens ... The Future of Specialty Contact Lenses

Keep Reading

How to Navigate the Ever-Changing Economics of Contact Lens Practice

News

The economics of contact lens practice have changed dramatically over the past 50 years. When soft contact lenses first became widely available, contact lens sales were a major component of an optometry practice’s business model, alongside routine eye examinations and optical sales. Today, however, advances in lens technology, changing patient expectations, increased competition, and the ... How to Navigate the Ever-Changing Economics of Contact Lens Practice

Keep Reading

Study Finds Soft Contact Lens Patients Significantly More Profitable than Glasses-Only Wearers

News

A new study commissioned by the Contact Lens Institute (CLI) finds that soft contact lens patients generate considerably more annual profit for eye care practices than patients who wear glasses exclusively. The study estimates that contact lens prescribing produces a profitability advantage ranging from 29% to 86%, depending on the type of vision correction being ... Study Finds Soft Contact Lens Patients Significantly More Profitable than Glasses-Only Wearers

Keep Reading

Harrow Acquires Global Rights To Tyrvaya

News

Harrow has entered into a definitive agreement with Viatris to acquire the global rights to Tyrvaya (varenicline solution) nasal spray 0.03 mg, a prescription treatment for the signs and symptoms of dry eye disease (DED). Announced August 6, 2026, the deal is valued at up to $100 million, consisting of a $30 million upfront cash ... Harrow Acquires Global Rights To Tyrvaya

Keep Reading

Hubble Launches Classic 2.0 Daily Contact Lens

News

Hubble has announced the nationwide launch of Classic 2.0, an updated version of its flagship daily disposable contact lens. The new lens represents the company’s effort to improve the comfort and wearing experience of its original Classic lens while maintaining the accessibility of a daily disposable product. According to Hubble, Classic 2.0 is designed with ... Hubble Launches Classic 2.0 Daily Contact Lens

Keep Reading

Bausch + Lomb Launches EyeGility Preloaded IOL Delivery System in US

News

Bausch + Lomb has introduced the EyeGility preloaded intraocular lens (IOL) delivery system in the United States, marking another step toward improving efficiency and consistency in cataract surgery. Designed for use with the company’s enVista family of IOLs, the EyeGility system arrives with the lens already loaded into a single-use injector. This eliminates the need ... Bausch + Lomb Launches EyeGility Preloaded IOL Delivery System in US

Keep Reading

Barriers to Accessible Ophthalmic Imaging Device Uptake: An Exploratory Study Of Ophthalmology Care Provider Perspectives

News

Modern eye care relies heavily on imaging technologies such as optical coherence tomography (OCT), fundus cameras, and visual field analyzers to diagnose and monitor eye disease. However, many of these devices were designed for patients who can easily sit upright, position their head on a chinrest, and remain still during testing. This creates significant challenges ... Barriers to Accessible Ophthalmic Imaging Device Uptake: An Exploratory Study Of Ophthalmology Care Provider Perspectives

Keep Reading

Vision In The Valley, Debuts In The Desert: An AOA 2026 Recap

News

The 2026 American Optometric Association (AOA) Congress and Optometry’s Meeting in Phoenix showcased many of the innovations expected to shape eye care over the coming years. The conference brought together clinicians, researchers, students, and industry leaders to discuss new technologies, clinical research, and evolving standards of care. Among the biggest themes were advances in contact ... Vision In The Valley, Debuts In The Desert: An AOA 2026 Recap

Keep Reading

Pediatric and Strabismus Care: Evolving Tools, Emerging Therapies

News

Pediatric ophthalmology is undergoing a significant transformation thanks to advances in imaging, diagnostics, genetics, and treatment options. Experts interviewed in the article explain that technologies such as handheld optical coherence tomography (OCT), widefield retinal imaging, and tele-ophthalmology are making it easier to diagnose and monitor eye conditions in infants and young children, even in patients ... Pediatric and Strabismus Care: Evolving Tools, Emerging Therapies

Keep Reading

FDA Class II Recall Of Prednisolone Acetate Ophthalmic Suspension

News

The U.S. Food and Drug Administration classified a nationwide recall affecting more than 2.5 million bottles of prednisolone acetate ophthalmic suspension manufactured by Lupin Pharmaceuticals. The recall was initiated after reports identified foreign material within certain bottles, prompting concerns about product quality and patient safety. Prednisolone acetate is among the most commonly prescribed corticosteroid eye ... FDA Class II Recall Of Prednisolone Acetate Ophthalmic Suspension

Keep Reading

AMA Supports Recognizing Myopia As A Disease

News

At its recent House of Delegates meeting, the American Medical Association adopted policy supporting the recognition of myopia as a disease and encouraging broader insurance coverage for evidence-based myopia management. While this policy does not immediately change reimbursement practices, it represents an important step toward treating progressive myopia as a medical condition rather than simply ... AMA Supports Recognizing Myopia As A Disease

Keep Reading

Alcon and RxSight Collaborate on Adjustable Presbyopia-Correcting Intraocular Lenses

News

Alcon and RxSight announced a strategic collaboration to develop the next generation of premium intraocular lenses (IOLs) for cataract surgery. The partnership combines Alcon’s expertise in IOL design with RxSight’s Light Adjustable Lens (LAL) technology, which enables surgeons to fine-tune a patient’s prescription after surgery using targeted ultraviolet light treatments. The goal is to create ... Alcon and RxSight Collaborate on Adjustable Presbyopia-Correcting Intraocular Lenses

Keep Reading